Brazil vs Tanzania: Cause of death, by non-communicable diseases, ages 60+, male
Brazil
63.6%
in 2021
Tanzania
64.2%
in 2021
Brazil rank
113th
Tanzania rank
111th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Brazil
- Tanzania
How they compare
Tanzania currently reports 64.2% against 63.6% in Brazil, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Brazil ahead.
Brazil ranks 113th and Tanzania ranks 111th of 185 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.5% | 47.8% | 39.7% | Brazil |
| 2010s | 83.4% | 59.7% | 23.6% | Brazil |
| 2020s | 66.4% | 64.9% | 1.5% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Brazil or Tanzania?
- Tanzania, at 64.2% against 63.6% in Brazil as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Brazil and Tanzania?
- 0.6%, with Tanzania ahead.
- How many years of comparable data are there for Brazil and Tanzania?
- 6 years are reported by both, from 2000 to 2021.
- How do Brazil and Tanzania rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Brazil ranks 113th and Tanzania ranks 111th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.